Psoriatic arthritis - etanercept, infliximab and adalimumab review proposal: Appendix B proposal paper presented to the Institute's Guidance Executive
Psoriatic arthritis - etanercept, infliximab and adalimumab review proposal: Appendix B proposal paper presented to the Institute's Guidance Executive
13 June 2013 (467.84 Kb 16 sec) |
This page was last updated: 22 August 2014